APPLICATION
ANDA062726
TYPE
ANDA
ORIGINAL APPROVAL
1987-03-06
LATEST ACTION
1998-05-04
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
KANTREXDiscontinued
KANAMYCIN SULFATE EQ 500MG BASE · CAPSULE · ORAL
Approval history
1998-05-04Manufacturing (CMC) · Supplement 7AP
1998-05-04Manufacturing (CMC) · Supplement 6AP
1996-07-03Manufacturing (CMC) · Supplement 5AP
1996-03-27Manufacturing (CMC) · Supplement 4AP
1993-04-26Labeling · Supplement 3AP
1990-04-10Labeling · Supplement 2AP
1987-03-06OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.